Lili Wen
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
LIPA-driven reprogramming of tumor-associated macrophages shapes an immunosuppressive microenvironment in osteosarcoma.
Journal: International immunopharmacology
Published: November 11, 2025
Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 02, 2025
Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2025
Single-cell profiling of SLC family transporters: uncovering the role of SLC7A1 in osteosarcoma.
Journal: Journal of translational medicine
Published: October 22, 2024
Ceramide metabolism-related prognostic signature and immunosuppressive function of ST3GAL1 in osteosarcoma.
Journal: Translational oncology
Published: September 30, 2023
Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
Journal: Journal of translational medicine
Published: August 22, 2023
Targeting NAT10 inhibits osteosarcoma progression via ATF4/ASNS-mediated asparagine biosynthesis.
Journal: Cell reports. Medicine
Published: August 08, 2023
M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression.
Journal: Oncogene
Published: September 20, 2021
Multimodal Risk-Adapted Treatment in Surgical Patients With Synovial Sarcoma: A Preoperative Nomogram-Guided Adjuvant Treatment Strategy.
Journal: Frontiers in surgery
Published: July 13, 2020
Comprehensive metabolomic profiling of osteosarcoma based on UHPLC-HRMS.
Journal: Metabolomics : Official journal of the Metabolomic Society
Published: April 03, 2020
Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Journal: Theranostics
Published: March 07, 2020
Comparison of local control and survival outcomes between surgical and non-surgical local therapy on pelvic Ewing's sarcoma patients: a meta-analysis.
Journal: Translational cancer research
Published: February 27, 2020
Last Updated: 09/26/2026